Mannatech Inc splits its revenue into 5 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $106.0 million, 98% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
|
108
|
118
|
132
|
137
|
160
|
151
|
158
|
174
|
177
|
180
|
| Consolidated Product Sales |
—
|
—
|
112
-10.4%
share 95.3%
|
125
-3.8%
share 95.0%
|
130
-13.8%
share 94.9%
|
151
+3.3%
share 94.5%
|
146
share 96.6%
|
—
|
—
|
—
|
—
|
| Product |
—
|
106
-8.5%
share 98.1%
|
116
share 98.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Consolidated Pack Sales |
—
|
—
|
4
-26.8%
share 3.5%
|
6
-9.7%
share 4.2%
|
6
-22.5%
share 4.5%
|
8
+90.5%
share 5.0%
|
4
share 2.8%
|
—
|
—
|
—
|
—
|
| Product And Service Other |
—
|
2
+6.7%
share 1.5%
|
2
+36.4%
share 1.3%
|
1
+37.5%
share 0.8%
|
1
+0.0%
share 0.6%
|
1
-20.0%
share 0.5%
|
1
share 0.7%
|
—
|
—
|
—
|
—
|
| Associate Service Fees |
—
|
0
-20.0%
share 0.4%
|
0
share 0.4%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- MTEX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Flower Mound, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1056358
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.